| Catalog # | Availability | Size | Quantity | Unit Price | Save For Later Wish List | |
|---|---|---|---|---|---|---|
| GRF0244-2 | 7 days | 2 µg | $120.00 |
Select product before adding to cart
|
||
| GRF0244-10 | 7 days | 10 µg | $290.00 | |||
| GRF0244-1 | 7 days | 1 mg | $8,320.00 |
Product Overview | |
| Name | LGALS8 Human, His |
|---|---|
| Description | |
| Galectin-8 Human Recombinant, His Tag | |
| Accession (Primary) | O00214 |
| Synonyms | |
| Galectin-8, Gal-8, LGALS-8, AI326142, D13Ertd524e, 1200015E08Rik. | |
| Introduction | |
| LGALS8 is a prostate-specific antigen that is solely overexpressed in malignant tumors and thus is a supplementary specific identifier of malignancies. LGALS8 is part of the galectin gene family which facilitates both cell-cell and cell matrix interactions in a method parallel to the selectin subgroup of C-type lectins. | |
| Source | |
| Escherichia Coli. | |
| Physical Appearance | |
| Sterile Filtered colorless solution. | |
| Formulation | |
| The LGALS8 solution (0.5mg/ml) contains 20mM Tris-HCl buffer (pH 8.0), 0.15M NaCl, 20% glycerol and 1mM DTT. | |
| Stability | |
| Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid multiple freeze-thaw cycles. | |
| Purity | |
| Greater than 90.0% as determined by SDS-PAGE. | |
| Amino acid sequence | |
| MGSSHHHHHH SSGLVPRGSH MGS MLSLNNL QNIIYNPIIP YVGTITEQLK PGSLIVIRGH VPKDSERFQV DFQLGNSLKP RADVAFHFNP RFKRSSCIVC NTLTQEKWGW EEITYDMPFR KEKSFEIVFM VLKNKFQVAV NGRHVLLYAH RISPEQIDTV GIYGKVNIHS IGFRFSSDLQ SMETSALGLT QINRENIQKP GKLQLSLPFE ARLNASMGPG RTVVIKGEVN TNARSFNVDL VAGKTRDIAL HLNPRLNVKA FVRNSFLQDA WGEEERNITC FPFSSGMYFE MIIYCDVREF KVAINGVHSL EYKHRFKDLS SIDTLSVDGD IRLLDVRSW. | |
| Biological Activity | |
| The ED 50 for this effect is ≤ 2ug/ml. Measured by its ability to agglutinate human red blood cells. | |
| Assay Conditions | |
| 1. Mix equal volumes of human blood and Alsever’s solution (pH 7.0). (Alsever’s solution: NaCl 0.42g, Sodium citric acid 0.8g, Citric acid 0.055g, D-glucose 2.05g in DW100 ml). 2. Centrifuge at 15000rpm for 10 minutes and wash 4 times with PBS. 3. Dilute packed cells in a 0.5mg/ml trypsin-EDTA solution to give 4% red cell suspension. 4. Incubate for 1 hour at 37°C and wash 4 times with PBS. 5. Dilute packed cells in PBS to give a 4% red cell suspension. 6. Load 50 µl of 0.5%BSA-in-0.15M-NaCl solution and 25 µl of 4%-Red-Cell-in-PBS in U shaped wells. 7. Add 25 µl of serial diluted galectin protein in PBS to each well plate (Round bottom 96 well plate). 8. Incubate for 30 minutes at room temperature to observe visible agglutination. | |
| Precautions | |
| LGALS8 Human, His is for research use only and not for use in diagnostic or therapeutic procedures. | |
Target Information: ( O00214 ) | |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from ADMEbio to advance their research.
Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
Thank you,
ADMEbio Team
ADMEbio welcomes feedback from our customers.
Thank you,
ADMEbio Team